A comparison of twice-daily calcipotriol ointment with once-daily short-contact dithranol cream therapy: quality-of-life outcomes of a randomized controlled trial of supervised treatment of psoriasis in a day-care setting

2007 ◽  
Vol 158 (2) ◽  
pp. 375-381 ◽  
Author(s):  
J. De Korte ◽  
P.G.M. Van Der Valk ◽  
M.A.G. Sprangers ◽  
R.J. Damstra ◽  
A.C.M. Kunkeler ◽  
...  
Keyword(s):  
Quality Of Life ◽  
Randomized Controlled Trial ◽  
Day Care ◽  
Care Setting ◽  
Controlled Trial ◽  
Life Outcomes ◽  
Once Daily ◽  
Randomized Controlled ◽  
Therapy Quality

scholarly journals Quality of life outcomes from a randomized controlled trial of patient navigation in Latina breast cancer survivors

2020 ◽  
Vol 9 (21) ◽  
pp. 7837-7848
Author(s):  
Amelie G. Ramirez ◽  
Edgar Muñoz ◽  
Dorothy Long Parma ◽  
Arely Perez ◽  
Alfredo Santillan
Keyword(s):  
Breast Cancer ◽  
Quality Of Life ◽  
Randomized Controlled Trial ◽  
Cancer Survivors ◽  
Breast Cancer Survivors ◽  
Patient Navigation ◽  
Controlled Trial ◽  
Life Outcomes ◽  
Randomized Controlled

scholarly journals Cardiac Remodelling in Patients Undergoing in-Centre Nocturnal Haemodialysis: Results from the MIDNIGHT Study, a Non-Randomized Controlled Trial

2017 ◽  
Vol 44 (4) ◽  
pp. 301-310 ◽  
Author(s):  
Matthew P.M. Graham-Brown ◽  
Darren R. Churchward ◽  
Katherine L. Hull ◽  
Rob Preston ◽  
Warren P. Pickering ◽  
...  
Keyword(s):  
Quality Of Life ◽  
Randomized Controlled Trial ◽  
Myocardial Fibrosis ◽  
Controlled Trial ◽  
Left Ventricular ◽  
Life Outcomes ◽  
Randomized Controlled ◽  
Native T1 ◽  
Clinical Measures

Evidence suggests extended-hours haemodialysis (HD) may improve cardiovascular, medical and quality-of-life outcomes. In-centre nocturnal haemodialysis (INHD) is an established but underutilized method of providing extended-hours treatment. This 6-month, non-randomized controlled trial (ISRCTN16672784) recruited 13 INHD patients and 12 control patients on conventional HD. The effects of treatment on left ventricular (LV) structure, function and myocardial fibrosis were assessed using cardiac magnetic resonance imaging and native T1 mapping. Quality-of-life and clinical measures were also collected. INHD led to significant reductions in LV mass (-14.75 vs. +6.54 g; p = 0.02), global T1 (-30.62 vs. 0.4 ms; p = 0.05) and non-septal native T1 values (-30.93 vs. 8.96 ms; p = 0.02) over time. There were also significant improvements in serum phosphate (-0.39 vs. +0.02 mmol/L; p = 0.03) and reductions in ultrafiltration rates (-2.32 vs. +0.70 mL/h/kg p = 0.05) between INHD and controls. Six-months of INHD was associated with favourable LV remodelling and reduced myocardial fibrosis compared to patients on conventional haemodialysis.

Sign in / Sign up

Export Citation Format

Share Document